Waters Corporation Presentation at the Barclays Capital 2013 Global Healthcare Conference to Be Webc
Waters Corporation Presentation at the Barclays Capital 2013 Global Healthcare Conference to Be Webcast Live
MILFORD, Mass.--(BUSINESS WIRE)-- Waters Corporation (NYS: WAT) John Ornell, Chief Financial Officer, will speak to the investment community at the Barclays Capital 2013 Global Healthcare Conference at the Loews Miami Hotel in Miami, Florida, on Wednesday, March 13th, at 9:00 a.m. eastern time.
Interested investors can access the live webcast of the presentation by logging on to Waters Corporation's website, www.waters.com in the investor relations' section, and clicking on "Barclays Capital Global Healthcare Conference."
About Waters Corporation:
For over 50 years, Waters Corporation (NYSE:WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.
Gene Cassis, 508-482-2349
V.P. Investor Relations
KEYWORDS: United States North America Florida Massachusetts
The article Waters Corporation Presentation at the Barclays Capital 2013 Global Healthcare Conference to Be Webcast Live originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.